Stay updated on Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.

Latest updates to the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page
- ChecktodayChange DetectedPublications section removed the safety-focused article on tralokinumab and the PubMed-sourced entry. A site-wide notice about a lapse in government funding and a new revision tag (Revision: v3.4.1) were added.SummaryDifference0.4%

- Check7 days agoChange DetectedUI and metadata updates include adding a 'Show glossary' option, minor capitalization changes (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data'), and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe update only changes revision labels (Revision: v3.3.4 added, Revision: v3.3.3 removed) and does not modify study data or essential page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedLocations now include Andalusia as a regional entry, and the old 'Andalusia Locations' grouping has been removed; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.1%

- Check72 days agoChange DetectedPubMed publications note updated to clarify automatic population from PubMed and that articles may not be about the study. Revision tag updated to v3.3.2.SummaryDifference0.1%

- Check79 days agoChange DetectedThe generic government funding/operational status notice was removed from the page. The study details, eligibility criteria, endpoints, and locations remain unchanged.SummaryDifference0.2%

Stay in the know with updates to Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.